Cara Therapeutics's total assets for Q1 2025 were $38.95M, a decrease of -11.13% from the previous quarter. CARA total liabilities were $47.02M for the fiscal quarter, a -2.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.